Vanilla

In Mesoamerica the cured pod was rarely taken on its own. It was mixed with cacao, and often with allspice, chilli or honey, in the Aztec chocolate drink.

The drink was taken as an aphrodisiac and as a stimulant for energy and stamina. Its reputation belonged to the drink as a whole, in which cacao and chilli were taken alongside the vanilla.

Vanilla reached Europe as a flavouring for chocolate and has remained chiefly a flavouring there.

In Western herbal practice it is a warming aromatic taken to settle the digestion and ease wind. It is also used to improve the taste of herbal formulas.

Vanillin is the only vanilla compound that has been tested in a human trial, and its use in sickle cell anaemia has been reviewed ^{4Reference 4Aruoma OI · 1992ReviewDietary management of sickle cell anaemia with vanillin — reviewView study →}.

Vanillin reacts covalently with sickle hemoglobin (Hb S), both in solution and in intact red cells. It shifts the oxygen-equilibrium curve to the left and inhibits sickling when the cells lose oxygen. X-ray crystallography places its main binding site in the central water cavity of the haemoglobin molecule ^{2Reference 2Abraham DJ et al. · 1991In vitroVanillin, a potential agent for the treatment of sickle cell anemia — in vitro / crystallographyView study →}.

In a double-blind, placebo-controlled trial of 30 sickle cell patients (11 on placebo), oral vanillin over 8 weeks increased the polymerization delay time about 1.6-fold and reduced sickled-cell counts by about 25% on a laboratory assay ^{1Reference 1García AF et al. · 2005RCTIn vivo action of Vanillin on delay time determined by magnetic relaxation — placebo-controlled clinical trialView study →}.

Because oral vanillin is rapidly broken down in the upper digestive tract, a prodrug (MX-1520) was developed. Given by mouth to transgenic sickle mice, it reduced sickled cells and prolonged survival under severe hypoxia ^{3Reference 3Zhang C et al. · 2004AnimalAnti-sickling effect of MX-1520, a prodrug of vanillin: an in vivo study using rodents — animal modelView study →}.

Gap: The human data are one small 2005 trial measuring a laboratory polymerization endpoint, not clinical crises or hemoglobin outcomes. The therapeutic form is an engineered prodrug, not vanilla, and whether culinary vanilla delivers any meaningful vanillin dose to the blood is untested ^{1,3Reference 1García AF et al. · 2005RCTIn vivo action of Vanillin on delay time determined by magnetic relaxation — placebo-controlled clinical trialView study →Reference 3Zhang C et al. · 2004AnimalAnti-sickling effect of MX-1520, a prodrug of vanillin: an in vivo study using rodents — animal modelView study →}.

Vanillin suppresses the NF-κB inflammatory pathway. In lipopolysaccharide-stimulated mouse macrophages it inhibited NF-κB activation and COX-2 gene expression more strongly than guaiacol, while eugenol had no effect ^{5Reference 5Murakami Y et al. · 2007In vitroRe-evaluation of cyclooxygenase-2-inhibiting activity of vanillin and guaiacol in macrophages stimulated with lipopolysaccharide — in vitroView study →}.

In human THP-1 monocytes it lowered TNF-α, IL-1β, IL-6 and IL-8, blocked the NF-κB/AP-1 pathway and the NLRP3 inflammasome, and activated the antioxidant Nrf2/HO-1 pathway ^{6Reference 6Zhao D et al. · 2019In vitroElucidation of the anti-inflammatory effect of vanillin in LPS-activated THP-1 cells — in vitroView study →}.

Comparable effects appear in LPS-stimulated microglia ^{7Reference 7Kim ME et al. · 2019In vitroAnti-neuroinflammatory effects of vanillin through the regulation of inflammatory factors and NF-κB signaling in LPS-stimulated microglia — in vitroView study →} and in a mouse model of acute lung injury, where vanillin inhibited ERK1/2, p38 and NF-κB signaling ^{9Reference 9Guo T et al. · 2019AnimalVanillin protects lipopolysaccharide-induced acute lung injury by inhibiting ERK1/2, p38 and NF-κB pathway — animal modelView study →}.

The oxidized metabolite vanillic acid shares the NF-κB-suppressing activity ^{8Reference 8Kim MC et al. · 2011In vitroVanillic acid inhibits inflammatory mediators by suppressing NF-κB in lipopolysaccharide-stimulated mouse peritoneal macrophages — in vitroView study →}.

All of it is cell-culture and rodent work, and the concentrations used in vitro may exceed what oral vanilla could deliver to tissue ^{6Reference 6Zhao D et al. · 2019In vitroElucidation of the anti-inflammatory effect of vanillin in LPS-activated THP-1 cells — in vitroView study →}.

Vanillin’s antioxidant activity depends on the assay. Vanillin was more potent than ascorbic acid and Trolox in the ORAC, ABTS and oxidative-hemolysis assays, yet showed no activity in the DPPH and galvinoxyl radical assays, because it reacts with radicals by forming dimers with itself rather than by simple hydrogen donation ^{10Reference 10Tai A et al. · 2011In vitroEvaluation of antioxidant activity of vanillin by using multiple antioxidant assays — in vitroView study →}.

Oral vanillin raised vanillin levels and antioxidant activity in the plasma of mice ^{10Reference 10Tai A et al. · 2011In vitroEvaluation of antioxidant activity of vanillin by using multiple antioxidant assays — in vitroView study →}.

In a comparative series, vanillyl alcohol and vanillic acid outperformed vanillin in three model radical assays. The synthetic analogue ethyl vanillin raised plasma antioxidant activity in mice more than vanillin did ^{11Reference 11Tai A et al. · 2011In vitroAntioxidant properties of ethyl vanillin in vitro and in vivo — animal modelView study →}.

The strongest numbers come from in-vitro chemistry, and the results diverge sharply by assay ^{10,11Reference 10Tai A et al. · 2011In vitroEvaluation of antioxidant activity of vanillin by using multiple antioxidant assays — in vitroView study →Reference 11Tai A et al. · 2011In vitroAntioxidant properties of ethyl vanillin in vitro and in vivo — animal modelView study →}.

Vanillin has been protective in several independent rodent models, through antioxidant and anti-inflammatory mechanisms. In a 6-hydroxydopamine rat model of Parkinson’s disease, oral or injected vanillin at 20 mg/kg/day preserved striatal dopamine ^{12Reference 12Abuthawabeh R et al. · 2020AnimalThe beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson’s disease — animal modelView study →}. In an MPTP mouse model it improved motor function, modulated Wnt/β-catenin and GSK-3β signaling, and reduced neuronal death ^{13Reference 13Rani L · 2024AnimalVanillin mitigates the MPTP-induced α-synucleinopathy in a mouse model of Parkinson’s disease — animal modelView study →}.

In neonatal hypoxic-ischemic rats it reduced infarct volume and protected the blood-brain barrier ^{14Reference 14Lan XB et al. · 2019AnimalNeuroprotective effect of vanillin on hypoxic-ischemic brain damage in neonatal rats — animal modelView study →}. In gerbils it reduced hippocampal CA1 cell death after global ischemia, an effect shared by the related molecules 4-hydroxybenzyl alcohol and 4-hydroxybenzaldehyde ^{15Reference 15Kim HJ et al. · 2007AnimalVanillin, 4-hydroxybenzyl aldehyde and 4-hydroxybenzyl alcohol prevent hippocampal CA1 cell death following global ischemia — animal modelView study →}.

In vitro, it protected dopaminergic SH-SY5Y cells against rotenone by preserving mitochondrial membrane potential ^{16Reference 16Dhanalakshmi C et al. · 2015In vitroNeurosupportive role of vanillin on rotenone-induced neurotoxicity in SH-SY5Y neuroblastoma cells — in vitroView study →}.

Gap: Broad and replicated but all preclinical, dosed by injection or gavage at levels (20–80 mg/kg) far above dietary exposure; no human neuroprotection data exist ^{12,14Reference 12Abuthawabeh R et al. · 2020AnimalThe beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson’s disease — animal modelView study →Reference 14Lan XB et al. · 2019AnimalNeuroprotective effect of vanillin on hypoxic-ischemic brain damage in neonatal rats — animal modelView study →}.

In carbon-tetrachloride-poisoned rats, vanillin pretreatment blunted the rise in plasma ALT and AST, inhibited hepatic lipid peroxidation and protein-carbonyl formation, restored catalase, superoxide dismutase and glutathione, lowered TNF-α, IL-1β and IL-6, and reduced necrosis on histology ^{17Reference 17Makni M et al. · 2011AnimalEvaluation of the antioxidant, anti-inflammatory and hepatoprotective properties of vanillin in carbon tetrachloride-treated rats — animal modelView study →}. The authors attributed the effect to its antioxidant and anti-inflammatory activity.

That is one toxin model in one species, with no other injury models and no human liver data ^{17Reference 17Makni M et al. · 2011AnimalEvaluation of the antioxidant, anti-inflammatory and hepatoprotective properties of vanillin in carbon tetrachloride-treated rats — animal modelView study →}.

In fructose–streptozotocin type-2-diabetic rats, oral vanillin (150–300 mg/kg, 5 weeks) lowered blood glucose, cholesterol and triglycerides, raised insulin and improved pancreatic β-cell function and structure, while restoring tissue glutathione and antioxidant enzymes and lowering α-amylase activity ^{20Reference 20Salau VF et al. · 2024AnimalVanillin improves glucose homeostasis and modulates metabolic activities linked to type 2 diabetes in fructose-streptozotocin induced diabetic rats — animal modelView study →}. A parallel study from the same group reported improved glucose uptake and reduced oxidative and purinergic dysfunction in diabetic skeletal muscle ^{21Reference 21Salau VF et al. · 2021AnimalVanillin modulates activities linked to dysmetabolism in psoas muscle of diabetic rats — animal modelView study →}.

Both studies come from one research group using one rodent model, and they have not been independently replicated ^{20,21Reference 20Salau VF et al. · 2024AnimalVanillin improves glucose homeostasis and modulates metabolic activities linked to type 2 diabetes in fructose-streptozotocin induced diabetic rats — animal modelView study →Reference 21Salau VF et al. · 2021AnimalVanillin modulates activities linked to dysmetabolism in psoas muscle of diabetic rats — animal modelView study →}.

Vanillin has measurable antibacterial activity. It damages the cell membrane and disrupts energy metabolism in Escherichia coli O157:H7, with a minimum inhibitory concentration of 2 mg/mL ^{22Reference 22Chen P et al. · 2023In vitroAntibacterial mechanism of vanillin against Escherichia coli O157:H7 — in vitroView study →}. A literature review documents activity of vanillin and vanillic acid against multidrug-resistant ESKAPE pathogens, often synergistic with antibiotics ^{23Reference 23Maisch NA et al. · 2022ReviewAntibacterial effects of vanilla ingredients provide novel treatment options for infections with multidrug-resistant bacteria — reviewView study →}.

Gap: In-vitro only, at concentrations relevant to food preservation rather than systemic infection; no evidence that ingested vanilla reaches antibacterial levels anywhere but the gut ^{22,23Reference 22Chen P et al. · 2023In vitroAntibacterial mechanism of vanillin against Escherichia coli O157:H7 — in vitroView study →Reference 23Maisch NA et al. · 2022ReviewAntibacterial effects of vanilla ingredients provide novel treatment options for infections with multidrug-resistant bacteria — reviewView study →}.

Rodent behavioral work suggests a mood effect, partly through smell. In mice, oral vanillin reduced immobility in the tail-suspension test, though the forced-swim result did not reach significance ^{18Reference 18Shoeb A et al. · 2013AnimalEvaluation of antidepressant activity of vanillin in mice — animal modelView study →}. In rat models of chronic stress and olfactory bulbectomy, vanillin raised brain serotonin and dopamine and eased depression-like behavior through the olfactory pathway ^{19Reference 19Xu J et al. · 2015AnimalVanillin-induced amelioration of depression-like behaviors in rats by modulating monoamine neurotransmitters in the brain — animal modelView study →}.

These are animal behavioural models with mixed results within studies. Because the proposed route is olfactory, the effective “dose” is as much aroma as ingestion ^{18,19Reference 18Shoeb A et al. · 2013AnimalEvaluation of antidepressant activity of vanillin in mice — animal modelView study →Reference 19Xu J et al. · 2015AnimalVanillin-induced amelioration of depression-like behaviors in rats by modulating monoamine neurotransmitters in the brain — animal modelView study →}.

The findings point in both directions. Orally administered vanillin reduced lung metastases of 4T1 mouse breast cancer cells and, at non-cytotoxic concentrations, inhibited invasion and MMP-9 activity in vitro ^{24Reference 24Lirdprapamongkol K et al. · 2005In vitroVanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells — animal modelView study →}. In triple-negative breast cancer cells it induced ferroptosis via the KLF2/GPX4 axis ^{25Reference 25Wang J et al. · 2025In vitroVanillin restrains proliferation of triple negative breast cancer cells by inducing ferroptosis via the KLF2/GPX4 axis — in vitroView study →}.

In azoxymethane-treated rats, however, high-dose (300 mg/kg) intraperitoneal vanillin increased pre-cancerous aberrant crypt foci in the colon, while oral vanillin had no effect either way ^{26Reference 26Ho KL et al. · 2012AnimalVanillin differentially affects azoxymethane-injected rat colon carcinogenesis and gene expression — animal modelView study →}.

Gap: The anti-metastatic data are preclinical, and the opposing colon finding means the net effect depends on dose, route and tissue; nothing supports vanilla as a cancer therapy ^{24,26Reference 24Lirdprapamongkol K et al. · 2005In vitroVanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells — animal modelView study →Reference 26Ho KL et al. · 2012AnimalVanillin differentially affects azoxymethane-injected rat colon carcinogenesis and gene expression — animal modelView study →}.

In a single ex-vivo study, vanillin relaxed pre-contracted rat mesenteric resistance arteries in a concentration-dependent, endothelium-independent manner, apparently by inhibiting extracellular Ca²⁺ influx rather than acting through nitric oxide, potassium channels or COX ^{29Reference 29Choi S et al. · 2022AnimalVanillin induces relaxation in rat mesenteric resistance arteries by inhibiting extracellular Ca²⁺ influx — animal modelView study →}.

That is one ex-vivo artery preparation, with no whole-animal blood-pressure data ^{29Reference 29Choi S et al. · 2022AnimalVanillin induces relaxation in rat mesenteric resistance arteries by inhibiting extracellular Ca²⁺ influx — animal modelView study →}.

Food use. Vanillin is on the GRAS (generally regarded as safe) list as a food additive ^{2Reference 2Abraham DJ et al. · 1991In vitroVanillin, a potential agent for the treatment of sickle cell anemia — in vitro / crystallographyView study →}. A rat study found no toxic effect on blood, liver or kidney at 150 and 300 mg/kg, given by mouth or by injection. The highest injected dose left the rats unconscious ^{27Reference 27Ho K et al. · 2011AnimalToxicology study of vanillin on rats via oral and intra-peritoneal administration — animal modelView study →}.

Allergy. Workers who handle vanilla can develop dermatitis, which has been attributed to calcium oxalate crystals in the plant ^{33Reference 33Fern · 2014Vanilla planifolia — habit, native range, cultivation, uses and known hazards — reference databaseView study →}. Allergy to eaten vanilla, with mouth ulceration or nausea, has also been reported.

Adulteration. Most commercial “vanilla” flavour is synthetic vanillin. Tonka bean, which is rich in coumarin, has been used as an adulterant.

Interactions. No human or animal study has tested vanilla or vanillin alongside prescription drugs. Vanilla is regulated as a food flavouring, and medicinal amounts, as opposed to culinary ones, have not been assessed for interactions.